CYP2C19*2 status in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis

CYP2C19*2 status in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis

Amanda J Laska,1 Marie J Han,1 Josh A Lospinoso,2 Patrick J Brown,1 Thomas M Beachkofsky1 1Department of Dermatology, San Antonio Uniformed Services Health Education Consortium, San Antonio, TX, 2780th Military Intelligence Brigade, Ft Meade, MD, USA Purpose: Genetic polymorphisms have been linked t...

Full description

Bibliographic Details
Main Authors: Laska AJ, Han MJ, Lospinoso JA, Brown PJ, Beachkofsky TM
Format: Article
Language:English
Published: Dove Medical Press 2017-05-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
Drug reactions
drug metabolism
adverse events
dermatology
Online Access:https://www.dovepress.com/cyp2c192-status-in-patients-with-stevens-johnson-syndrome-and-toxic-ep-peer-reviewed-article-PGPM

Internet

https://www.dovepress.com/cyp2c192-status-in-patients-with-stevens-johnson-syndrome-and-toxic-ep-peer-reviewed-article-PGPM

Similar Items